Relationship of clinical deterioration in leprosy patients while on multidrug therapy with their glucose-6-phosphate dehydrogenase levels
Background: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is known to cause haemolysis in patients with Hansen's disease receiving dapsone containing multidrug-therapy (MDT). However, sparse recent data are available on this topic from India. Methods: All patients aged over 10 years with...
Main Authors: | Abhishek Sharma, D Ramachandra Reddy, Prathap Reddy, Bhumesh Tyagi, Shivanu Mathon, Suryash Jain |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Journal of Clinical and Scientific Research |
Subjects: | |
Online Access: | http://www.jcsr.co.in/article.asp?issn=2277-5706;year=2018;volume=7;issue=2;spage=64;epage=68;aulast=Sharma |
Similar Items
-
Adverse effects of polychemotherapy for leprosy in 13 years of follow-up at a university hospital,
by: Violeta Duarte Tortelly, et al.
Published: (2021-05-01) -
DAPSONE-INDUCED TOXIC MACULOPATHY IN LEPROSY PATIENT
by: Sita Paramita Ayuningtyas, et al.
Published: (2023-03-01) -
DAPSONE-INDUCED TOXIC MACULOPATHY IN LEPROSY PATIENT
by: Sita Paramita Ayuningtyas, et al.
Published: (2023-03-01) -
Adverse reactions in leprosy patients who underwent dapsone multidrug therapy: a retrospective study
by: Guragain S, et al.
Published: (2017-06-01) -
Should prophylaxis against Pneumocystis jirovecii pneumonia be considered in selected patients with leprosy reactions?
by: Nuria Ramírez-Perea, et al.
Published: (2024-04-01)